Clinical Trials · NCT06868576
PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Kasr El Aini Hospital
- Enrollment
- 328
- Start date
- Jan 2023
- Locations
- 1 site, Egypt
- Primary endpoint
- clinical pregnancy